News Center

Home page

Peak Report

News reports

lead by example, overcome difficulties, open up and innovate

Release time:

2022-03-22

Looking back on the years of working in the municipal pharmaceutical company, my achievements cannot be separated from the training and support of the leaders of the group and the pharmaceutical industry, and cannot be separated from the strong support and cooperation of all colleagues. In recent years, municipal pharmaceutical companies have faced unfavorable factors of national policies and a fiercely competitive market, especially with the full implementation of the two-invoice system for drug sales in public hospitals and the rapid advancement of national and local centralized procurement, drug profit margins have been compressed., The distribution of drugs has been in a state of meager profit. In order to optimize personnel and save sales costs, drug sales channels have also become centralized, and drug distribution has been concentrated on commercial distribution companies covering the whole province. The city's pharmaceutical companies are facing competition from Zhejiang provincial-level commercial enterprises in terms of low prices, concessions, market grabbing and homogenization. As the person in charge of an enterprise, I have the responsibility to work with the team to lead a company with more than 100 employees and a history of 70 to overcome difficulties.

After careful market analysis, since the distribution of two-ticket products cannot compete with the distribution enterprises covered by the whole province, our way out lies in the distribution of non-two-ticket products. The goal is clear. On the one hand, we use the group's financial advantages to ensure the sales of existing products by improving services. On the other hand, we have targeted to expand the sales of non-two-vote products, especially special drugs, narcotic drugs, psychotropic drugs and Chinese herbal medicine decoction pieces, as well as OTC products. In addition, we have won their support through frequent market operation and repeated communication with relevant government departments, so that the pharmaceutical company continues to be the only municipal enterprise with special drug distribution qualification in Jinhua City, forming an effective industry barrier. At the same time, we have strengthened close contact with special drug suppliers, made every effort to provide good services, and actively cooperated with them in price maintenance, which not only ensured the interests of suppliers but also ensured the reasonable profits of our company. As the distribution profit margin of special drugs is much higher than that of ordinary drugs, the sharp increase in sales effectively makes up for the decline in sales of two-vote products.

While doing a good job in the sales increase of special drugs, we have vigorously expanded the sales of Chinese herbal pieces and improved our business with Tianshili Group. In 2021 , Health Technology Company processed Chinese herbal pieces to 1100 , bringing the sales of Chinese herbal pieces to a new level. In terms of increasing the sales of OTC , we have introduced the general distributors of well-known brands such as Donge Ejiao and Nanjing Tongrentang in Jinhua area, which not only expanded the sales, but also enhanced the company's influence in Jinhua area.

In order to seek the development of the company, the group purchased a plot of land in Jinxing South Street in the urban area to serve as a reserve for the relocation of the Huancheng East Road warehouse, which did not produce benefits. Through proper renovation, we have successfully hired more than 4 million rents since 2018 . 2021 At the beginning of the year, the plot was included in the government purchasing and storage plan of Jinhua Economic Development Zone. In order to obtain more land compensation, we have taken the initiative to connect with government departments such as development zones, natural resources and planning bureaus for many times, and at the same time compare the compensation levels of other depositors horizontally. Through efforts to coordinate and strive for it, we should also thank the general manager of the pharmaceutical industry for his strong support and realize the maximization of land compensation.

As secretary of the general party branch of the municipal pharmaceutical company, I set an example and distinguish between public and private. Insist on demanding yourself with high standards, take the lead in problems and face up to difficulties. All our party members can also play an exemplary role, making party members the backbone of the company. The general party branch of the pharmaceutical company has also won the title of "Advanced Party Organization " for many years. Under the vanguard and exemplary role of all party members, the cohesion of all employees has been greatly improved, which provides a strong guarantee for the sustainable and stable development of pharmaceutical companies.

In the new year, although the situation in the pharmaceutical industry is more severe, I will live up to my trust and lead all employees to overcome difficulties, pioneer and innovate, and strive for new victories. (According to Wu Weisheng's speech at the summary and commendation meeting of the pharmaceutical company)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页